Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by Dermatologists
Conclusions and Relevance: The results of a cSCC-GEP test appear to significantly impact decisions made by dermatologists regarding subsequent management, SLNBx, and follow-up intervals for patients with cSCC.
J Drugs Dermatol. 2019;18(10):980-984.
PMID: 31584775 [PubMed - as supplied by publisher]
Source: Journal of Drugs in Dermatology - Category: Dermatology Tags: J Drugs Dermatol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Conferences | Dermatology | Genetics | Immunotherapy | Skin | Skin Cancer | Squamous Cell Carcinoma | Statistics | Women